Associated Press
01.26.2005, 05:54 AM
German drug maker Bayer AG said Wednesday it has now settled more than 2,900 suits related to its cholesterol-lowering drug Lipobay, or Baycol, paying more than US$1.1 billion in out-of-court deals.
Bayer pulled Lipobay, marketed as Baycol in the United States, in 2001 after it was linked to a rare muscle-wasting syndrome and about 100 patient deaths.
In a regular posting to its Web site, the Leverkusen-based company said it has now settled 2,933 cases and agreed to pay a total of US$1.113 billion without admitting liability. Some 6,359 cases are still pending.
In November the company said it had reached settlements in 2,895 cases and paid some US$1.1 billion in out-of-court deals.
Posted by toni on January 27, 2005 09:50 AM
FAIR USE NOTICE: This site may contain copyrighted (C ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available for educational purposes, to advance understanding of human rights, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in the 'fair use doctrine'. The material is distributed without
profit.
